Synergy Pharmaceuticals shares spike after positive drug trial results
Synergy Pharmaceuticals | December 23, 2016
Shares of Synergy Pharmaceuticals skyrocketed more than 10 percent higher on Friday after the firm reported positive trial results for an irritable bowel syndrome drug. The drugmaker said preliminary data for plecanatide, an experimental once-daily tablet, met the main goal in second phase 3 study on irritable bowel syndrome patients with constipation…